SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
Keryx Biopharmaceuticals, Inc.(NASDAQ : KERX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading KERX News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.79%||86.55||1.6%||$778.69m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.47%||391.34||3.1%||$323.98m|
|ALXN||Alexion Pharmaceuticals, Inc.||-1.18%||125.80||2.6%||$289.82m|
|BMRN||BioMarin Pharmaceutical Inc.||0.24%||93.58||3.9%||$197.30m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.73%||93.89||1.7%||$132.65m|
|JUNO||Juno Therapeutics, Inc.||1.04%||29.13||7.9%||$106.11m|
|A||Agilent Technologies, Inc.||-0.21%||46.57||1.9%||$100.85m|
|ACAD||ACADIA Pharmaceuticals Inc.||1.36%||36.55||13.1%||$79.16m|
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.